ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
LISCure Biosciences announces research collaboration with Mayo Clinic for rare liver diseases
January 07, 2022LISCure Biosciences Inc., a leading biotech focused on microbial-based therapeutics, announced that it has executed a research collaboration agreement with Mayo Clinic for new drug development for rare liver diseases. -
LISCure Biosciences completes seed funding of $5M
July 28, 2019Furthermore, a series of studies published recently suggested that the treatment rate of immunosuppressants is affected by the intestinal microbiological environment. Microbiomes have emerged as a means that can improve the low response rate of immunosupp
Pharma Sources Insight January 2025
